30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Bright Minds Biosciences Inc (DRUG)

Track

Over the last 90 days, Bright Minds Biosciences Inc. has seen significant net selling activity, with total sales exceeding $10.4 million and total buys at approximately $99,256. This trend is primarily driven by large sell-offs from a former 10% owner. Executive net activity was minimal. The stock price has declined by 17.5% in the same period.
Stock chart
Ticker: DRUG Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
McDonald, Ian
Director of Issuer, Senior Officer of Issuer
1 purchase — total 100,000 USD
Buy 12 Jun 2026
Value US$348,641.80 | Price 81.87 | Shares 92,186
Sale 1 Jun 2026
Value US$2,697,858.34 | Price 216.32 | Shares 36,747
Sale 30 Apr 2026
Value CA$242,000.00 | Price 121.00 | Shares 2,000
Sale 30 Apr 2026
Value CA$60,870.00 | Price 121.74 | Shares 500
Sale 28 Apr 2026
Value US$100,000.00 | Price 89.50 | Shares 1,000
Sale 28 Apr 2026
Value US$9,785,124.50 | Price 89.50 | Shares 109,331
Sale 2 Apr 2025
Value CA$120,960.00 | Price 50.40 | Shares 2,400
Sale 6 Dec 2024
Value CA$1,411,795.00 | Price 56.47 | Shares 25,000
Sale 12 Nov 2024
Value US$653,408.00 | Price 40.84 | Shares 16,000
Sale 8 Nov 2024
Value CA$7,108.00 | Price 71.08 | Shares 100
Sale 7 Nov 2024
Value CA$391,902.00 | Price 79.98 | Shares 4,900
Sale 5 Nov 2024
Value CA$31,172.00 | Price 77.93 | Shares 400
Buy 4 Nov 2024
Value US$4,099,998.00 | Price 21.70 | Shares 188,940
Buy 4 Nov 2024
Value US$100,015.30 | Price 21.70 | Shares 4,609
Sale 4 Nov 2024
Value US$248,975.00 | Price 49.80 | Shares 5,000
Buy 4 Nov 2024
Value US$3,999,982.70 | Price 21.70 | Shares 184,331
Sale 16 Oct 2024
Value CA$12,084,000.00 | Price 40.28 | Shares 300,000
Buy 16 Oct 2024
Value US$78,364.75 | Price 25.22 | Shares 3,107
Buy 16 Oct 2024
Value US$171,814.50 | Price 24.03 | Shares 7,150
Buy 16 Oct 2024
Value US$922,633.74 | Price 23.22 | Shares 39,743
Sale 15 Oct 2024
Value CA$96,696.00 | Price 40.29 | Shares 2,400
Buy 15 Oct 2024
Value US$56,927.14 | Price 12.35 | Shares 4,609
Buy 15 Oct 2024
Value US$224,601.26 | Price 11.72 | Shares 19,169
Buy 15 Oct 2024
Value US$25,008.48 | Price 9.26 | Shares 2,700
Buy 15 Oct 2024
Value US$22,890.40 | Price 8.80 | Shares 2,600
Buy 15 Oct 2024
Value US$65,016.28 | Price 7.31 | Shares 8,900
Buy 15 Oct 2024
Value US$214,218.77 | Price 6.42 | Shares 33,343
Buy 15 Oct 2024
Value US$374,236.85 | Price 5.92 | Shares 63,173
Buy 15 Oct 2024
Value US$1,078,674.65 | Price 4.53 | Shares 238,097
Sale 8 Aug 2023
Value CA$22,428.00 | Price 6.23 | Shares 3,600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 B Purchase
1.4
McDonald, Ian

Director of Issuer, Senior Officer of Issuer

Executive Director
92,186 +20.5%
81.87
US$348,642 		92,186 +20.5% 81.87 US$348,642
2026-06-09 2026-06-01 S Sale
2.7
Bottler, Nils

Director of Issuer

Non-Executive Director
36,747
216.32
US$2,697,858 		36,747 216.32 US$2,697,858
2026-04-30 2026-04-30 S Sale
Vasilkevich, Alex

Senior Officer of Issuer

Officer
12,876 -20.7%
57.76
CA$2,763,915 		12,876 -20.7% 57.76 CA$2,763,915
2026-04-30 2026-04-30 S Sale
Vasilkevich, Alex

Senior Officer of Issuer

Officer
500 -2.5%
121.74
CA$60,870 		500 -2.5% 121.74 CA$60,870
2026-06-19 2026-04-28 S Sale
Cormorant Asset Management LP

10% Security Holder of Issuer

Large shareholder
1,000 -10.3%
89.50
US$100,000 		1,000 -10.3% 89.50 US$100,000
2026-04-30 2026-04-28 S Sale
3.8
Cormorant Asset Management, LP

Former 10% Owner
109,331 -10.3%
89.50
US$9,785,124 		109,331 -10.3% 89.50 US$9,785,124
2025-04-06 2025-04-02 S Sale
2.9
Pedersen, Jan Torleif

Director of Issuer

Non-Executive Director
2,400 -4.0%
50.40
CA$120,960 		2,400 -4.0% 50.40 CA$120,960
2024-12-10 2024-12-06 S Sale
2.9
Pedersen, Jan Torleif

Director of Issuer

Non-Executive Director
25,000 -41.7%
56.47
CA$1,411,795 		25,000 -41.7% 56.47 CA$1,411,795
2024-11-13 2024-11-12 S Sale
2.7
Bottler, Nils

Director of Issuer

Non-Executive Director
16,000 -76.2%
40.84
US$653,408 		16,000 -76.2% 40.84 US$653,408
2024-11-11 2024-11-08 S Sale
3.2
Cheung, Ryan

Senior Officer of Issuer

Officer
100
71.08
CA$7,108 		100 71.08 CA$7,108
2024-11-11 2024-11-07 S Sale
3.2
Cheung, Ryan

Senior Officer of Issuer

Officer
4,900 -98.0%
79.98
CA$391,902 		4,900 -98.0% 79.98 CA$391,902
2024-11-08 2024-11-05 S Sale
2.7
Bottler, Nils

Director of Issuer

Non-Executive Director
400 -7.4%
77.93
CA$31,172 		400 -7.4% 77.93 CA$31,172
2024-11-08 2024-11-04 B Purchase
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
188,940 +4099.4%
21.70
US$4,099,998 		188,940 +4099.4% 21.70 US$4,099,998
2024-11-08 2024-11-04 S Sale
2.7
Bottler, Nils

Director of Issuer

Non-Executive Director
5,000 -48.1%
49.80
US$248,975 		5,000 -48.1% 49.80 US$248,975
2024-11-07 2024-11-04 B Purchase
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
4,609
21.70
US$100,015 		4,609 21.70 US$100,015
2024-11-06 2024-11-04 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
184,331 +21.1%
21.70
US$3,999,983 		184,331 +21.1% 21.70 US$3,999,983
2024-10-26 2024-10-16 S Sale
1.4
McDonald, Ian

Director of Issuer, Senior Officer of Issuer

Executive Director
300,000 -30.8%
40.28
CA$12,084,000 		300,000 -30.8% 40.28 CA$12,084,000
2024-10-17 2024-10-16 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
3,107 +0.4%
25.22
US$78,365 		3,107 +0.4% 25.22 US$78,365
2024-10-17 2024-10-16 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
7,150 +0.8%
24.03
US$171,814 		7,150 +0.8% 24.03 US$171,814
2024-10-17 2024-10-16 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
39,743 +4.8%
23.22
US$922,634 		39,743 +4.8% 23.22 US$922,634
2024-10-23 2024-10-15 S Sale
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
2,400 -9.1%
40.29
CA$96,696 		2,400 -9.1% 40.29 CA$96,696
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
4,609 +0.6%
12.35
US$56,927 		4,609 +0.6% 12.35 US$56,927
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
19,169 +2.4%
11.72
US$224,601 		19,169 +2.4% 11.72 US$224,601
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
2,700 +0.3%
9.26
US$25,008 		2,700 +0.3% 9.26 US$25,008
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
2,600 +0.3%
8.80
US$22,890 		2,600 +0.3% 8.80 US$22,890
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
8,900 +1.1%
7.31
US$65,016 		8,900 +1.1% 7.31 US$65,016
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
33,343 +4.4%
6.42
US$214,219 		33,343 +4.4% 6.42 US$214,219
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
63,173 +9.1%
5.92
US$374,237 		63,173 +9.1% 5.92 US$374,237
2024-10-17 2024-10-15 B Purchase
3.8
Cormorant Asset Management, LP
Large shareholder
238,097 +52.6%
4.53
US$1,078,675 		238,097 +52.6% 4.53 US$1,078,675
2023-08-09 2023-08-08 S Sale
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
3,600 -60.0%
6.23
CA$22,428 		3,600 -60.0% 6.23 CA$22,428
Explore more

More insider trading research around Bright Minds Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America